A comprehensive view of European Commission. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Wood & Building Products Market Intelligence Service.
European Commission approves Merck’s KEYTRUDA pembrolizumab plus chemotherapy as neoadjuvant treatment, then continued as monotherapy as adjuvant treatment, for resectable non-small cell lung cancer at high risk of recurrence in adults
Published:
March 28, 2024
by Business Wire
|
European Commission plans expanded definition of 'advanced' biofuel, draws criticism from trade group EWABA, as changes would apply to aviation sector only; group says move disrupts fairness across sectors, undermines investments in biofuel supply chain
Published:
March 22, 2024
by EWABA
|
EU panel recommends approval of Novo Nordisk's weekly insulin therapy, Awiqli, based on successful Phase 3 clinical trials; European Commission decision awaited
Published:
March 22, 2024
by SeeNews Pharmaceuticals
|
Novartis AG gets positive opinion from CHMP for Fabhalta paroxysmal nocturnal hemoglobinuria treatment for adults; the therapy awaits final European Commission approval in the next two months, potentially becoming Europe's first oral monotherapy for PNH
Published:
March 22, 2024
by dpa-AFX International Compact
|
Horizon Europe's PYSOLO project launches website; project seeks to combine concentrated solar power and biomass pyrolysis for decarbonizing chemical industry in EU
Published:
March 20, 2024
by Renewable Carbon Initiative (RCI)
|
Ask us about our Wood & Building Products market view